Obesity and hypertension.
Seravalle G, Grassi G.
Pharmacol Res. 2017 Aug;122:1-7. doi: 10.1016/j.phrs.2017.05.013. Epub 2017 May 19.
Obesity Phenotypes, Diabetes, and Cardiovascular Diseases.
Piché ME, Tchernof A, Després JP.
Circ Res. 2020 May 22;126(11):1477-1500. doi: 10.1161/CIRCRESAHA.120.316101. Epub 2020 May 21.
Humans against Obesity: Who Will Win?
Caballero B.
Adv Nutr. 2019 Jan 1;10(suppl_1):S4-S9. doi: 10.1093/advances/nmy055.
Contemporary medical, device, and surgical therapies for obesity in adults.
Perdomo CM, Cohen RV, Sumithran P, Clément K, Frühbeck G.
Lancet. 2023 Apr 1;401(10382):1116-1130. doi: 10.1016/S0140-6736(22)02403-5. Epub 2023 Feb 9.
Obesity as a disease: no lightweight matter.
Conway B, Rene A.
Obes Rev. 2004 Aug;5(3):145-51. doi: 10.1111/j.1467-789X.2004.00144.x.
The hematologic consequences of obesity.
Purdy JC, Shatzel JJ.
Eur J Haematol. 2021 Mar;106(3):306-319. doi: 10.1111/ejh.13560. Epub 2020 Dec 13.
Obesity and female infertility: potential mediators of obesity's impact.
Broughton DE, Moley KH.
Fertil Steril. 2017 Apr;107(4):840-847. doi: 10.1016/j.fertnstert.2017.01.017. Epub 2017 Mar 11.
Obesity's Impact.
Golden A.
Nurs Clin North Am. 2021 Dec;56(4):xiii-xiv. doi: 10.1016/j.cnur.2021.08.004.
Microbial Medicine: Prebiotic and Probiotic Functional Foods to Target Obesity and Metabolic Syndrome.
Green M, Arora K, Prakash S.
Int J Mol Sci. 2020 Apr 21;21(8):2890. doi: 10.3390/ijms21082890.
Metabolism and Metabolic Disorders and the Microbiome: The Intestinal Microbiota Associated With Obesity, Lipid Metabolism, and Metabolic Health-Pathophysiology and Therapeutic Strategies.
Aron-Wisnewsky J, Warmbrunn MV, Nieuwdorp M, Clément K.
Gastroenterology. 2021 Jan;160(2):573-599. doi: 10.1053/j.gastro.2020.10.057. Epub 2020 Nov 27.
